{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:02:57Z","timestamp":1789250577318,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2022M3A9B6017813"],"award-info":[{"award-number":["2022M3A9B6017813"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI23C1371"],"award-info":[{"award-number":["HI23C1371"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00394-025-03639-4","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:31:43Z","timestamp":1741609903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["6-Shogaol, a neuro-nutraceutical derived from ginger, alleviates motor symptoms and depression-like behaviors and modulates the release of monoamine neurotransmitters in Parkinson's disease mice"],"prefix":"10.1007","volume":"64","author":[{"given":"Jin Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Jee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Se","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Gyoung","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeyoon","family":"Eo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoung Y.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Pyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hi-Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8189-4066","authenticated-orcid":false,"given":"Myung Sook","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"8","key":"3639_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna) 124(8):901\u2013905. https:\/\/doi.org\/10.1007\/s00702-017-1686-y","journal-title":"J Neural Transm (Vienna)"},{"issue":"10423","key":"3639_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403(10423):283\u2013292. https:\/\/doi.org\/10.1016\/S0140-6736(23)01419-8","journal-title":"Lancet"},{"key":"3639_CR3","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"3639_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 1","key":"3639_CR5","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"RF Pfeiffer","year":"2016","unstructured":"Pfeiffer RF (2016) Non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 22(Suppl 1):S119-122. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"3639_CR6","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1007\/s12035-020-01941-2","volume":"57","author":"J Tang","year":"2020","unstructured":"Tang J, Lu L, Wang Q, Liu H, Xue W, Zhou T, Xu L, Wang K, Wu D, Wei F, Tao W, Chen G (2020) Crocin reverses depression-like behavior in Parkinson disease mice via VTA-mPFC pathway. Mol Neurobiol 57(7):3158\u20133170. https:\/\/doi.org\/10.1007\/s12035-020-01941-2","journal-title":"Mol Neurobiol"},{"issue":"2","key":"3639_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4103\/0253-7176.155611","volume":"37","author":"B Menon","year":"2015","unstructured":"Menon B, Nayar R, Kumar S, Cherkil S, Venkatachalam A, Surendran K, Deepak KS (2015) Parkinson\u2019s disease, depression, and quality-of-life. Indian J Psychol Med 37(2):144\u2013148. https:\/\/doi.org\/10.4103\/0253-7176.155611","journal-title":"Indian J Psychol Med"},{"issue":"3","key":"3639_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s1353-8020(01)00015-3","volume":"8","author":"LM Shulman","year":"2002","unstructured":"Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002) Non-recognition of depression and other non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 8(3):193\u2013197. https:\/\/doi.org\/10.1016\/s1353-8020(01)00015-3","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"3639_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/nedt.2006.2.3.349","volume":"2","author":"IH Richard","year":"2006","unstructured":"Richard IH, Kurlan R (2006) The under-recognition of depression in Parkinson\u2019s disease. Neuropsychiatr Dis Treat 2(3):349\u2013353. https:\/\/doi.org\/10.2147\/nedt.2006.2.3.349","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"3639_CR10","doi-asserted-by":"publisher","first-page":"R154","DOI":"10.1016\/j.cub.2005.02.037","volume":"15","author":"SE Hyman","year":"2005","unstructured":"Hyman SE (2005) Neurotransmitters. Curr Biol 15(5):R154-158. https:\/\/doi.org\/10.1016\/j.cub.2005.02.037","journal-title":"Curr Biol"},{"key":"3639_CR11","doi-asserted-by":"publisher","first-page":"903664","DOI":"10.3389\/fphar.2022.903664","volume":"13","author":"E Huh","year":"2022","unstructured":"Huh E, Kwon Y, Choi JG, Lim MG, Jeong JS, Park AY, Kim JH, Pak YK, Hong SP, Oh MS (2022) DA-9805, a herbal mixture, restores motor manifestations in 6-hydroxydopamine-induced Parkinson\u2019s disease mouse model by regulating striatal dopamine and acetylcholine levels. Front Pharmacol 13:903664. https:\/\/doi.org\/10.3389\/fphar.2022.903664","journal-title":"Front Pharmacol"},{"issue":"3","key":"3639_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","volume":"17","author":"P Barone","year":"2010","unstructured":"Barone P (2010) Neurotransmission in Parkinson\u2019s disease: beyond dopamine. Eur J Neurol 17(3):364\u2013376. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02900.x","journal-title":"Eur J Neurol"},{"issue":"2","key":"3639_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","volume":"275","author":"B Scatton","year":"1983","unstructured":"Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson\u2019s disease. Brain Res 275(2):321\u2013328. https:\/\/doi.org\/10.1016\/0006-8993(83)90993-9","journal-title":"Brain Res"},{"key":"3639_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23020466","author":"SC Ho","year":"2018","unstructured":"Ho SC, Chang YH (2018) Comparison of inhibitory capacities of 6-, 8- and 10-Gingerols\/Shogaols on the canonical NLRP3 inflammasome-mediated IL-1beta secretion. Molecules. https:\/\/doi.org\/10.3390\/molecules23020466","journal-title":"Molecules"},{"key":"3639_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22091477","author":"CM Liu","year":"2017","unstructured":"Liu CM, Kao CL, Tseng YT, Lo YC, Chen CY (2017) Ginger phytochemicals inhibit cell growth and modulate drug resistance factors in docetaxel resistant prostate cancer cell. Molecules. https:\/\/doi.org\/10.3390\/molecules22091477","journal-title":"Molecules"},{"issue":"1","key":"3639_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2014.04.121","volume":"449","author":"M Moon","year":"2014","unstructured":"Moon M, Kim HG, Choi JG, Oh H, Lee PK, Ha SK, Kim SY, Park Y, Huh Y, Oh MS (2014) 6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia. Biochem Biophys Res Commun 449(1):8\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.121","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3639_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4062\/biomolther.2023.098","volume":"31","author":"E Huh","year":"2023","unstructured":"Huh E, Choi JG, Choi Y, Ju IG, Noh D, Shin DY, Kim DH, Park HJ, Oh MS (2023) 6-Shogaol, an active ingredient of ginger, improves intestinal and brain abnormalities in proteus mirabilis-induced Parkinson\u2019s Disease Mouse Model. Biomol Ther (Seoul) 31(4):417\u2013424. https:\/\/doi.org\/10.4062\/biomolther.2023.098","journal-title":"Biomol Ther (Seoul)"},{"issue":"9","key":"3639_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/aps.2013.57","volume":"34","author":"G Park","year":"2013","unstructured":"Park G, Kim HG, Ju MS, Ha SK, Park Y, Kim SY, Oh MS (2013) 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson\u2019s disease models via anti-neuroinflammation. Acta Pharmacol Sin 34(9):1131\u20131139. https:\/\/doi.org\/10.1038\/aps.2013.57","journal-title":"Acta Pharmacol Sin"},{"key":"3639_CR19","doi-asserted-by":"publisher","first-page":"1181973","DOI":"10.3389\/fimmu.2023.1181973","volume":"14","author":"R Yin","year":"2023","unstructured":"Yin R, Zhang K, Li Y, Tang Z, Zheng R, Ma Y, Chen Z, Lei N, Xiong L, Guo P, Li G, Xie Y (2023) Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation. Front Immunol 14:1181973. https:\/\/doi.org\/10.3389\/fimmu.2023.1181973","journal-title":"Front Immunol"},{"issue":"3","key":"3639_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/a:1001958023096","volume":"30","author":"M Sedelis","year":"2000","unstructured":"Sedelis M, Hofele K, Auburger GW, Morgan S, Huston JP, Schwarting RK (2000) MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav Genet 30(3):171\u2013182. https:\/\/doi.org\/10.1023\/a:1001958023096","journal-title":"Behav Genet"},{"key":"3639_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.fct.2013.12.037","volume":"65","author":"HG Kim","year":"2014","unstructured":"Kim HG, Park G, Piao Y, Kang MS, Pak YK, Hong SP, Oh MS (2014) Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson\u2019s disease. Food Chem Toxicol 65:293\u2013300. https:\/\/doi.org\/10.1016\/j.fct.2013.12.037","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"3639_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/cns.12555","volume":"22","author":"XH Li","year":"2016","unstructured":"Li XH, Dai CF, Chen L, Zhou WT, Han HL, Dong ZF (2016) 7,8-dihydroxyflavone ameliorates motor deficits via suppressing alpha-synuclein expression and oxidative stress in the MPTP-induced mouse model of Parkinson\u2019s Disease. CNS Neurosci Ther 22(7):617\u2013624. https:\/\/doi.org\/10.1111\/cns.12555","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"3639_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2010.03.004","volume":"211","author":"TN Taylor","year":"2010","unstructured":"Taylor TN, Greene JG, Miller GW (2010) Behavioral phenotyping of mouse models of Parkinson\u2019s disease. Behav Brain Res 211(1):1\u201310. https:\/\/doi.org\/10.1016\/j.bbr.2010.03.004","journal-title":"Behav Brain Res"},{"issue":"1","key":"3639_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1515\/intox-2017-0006","volume":"10","author":"K Belovicova","year":"2017","unstructured":"Belovicova K, Bogi E, Csatlosova K, Dubovicky M (2017) Animal tests for anxiety-like and depression-like behavior in rats. Interdiscip Toxicol 10(1):40\u201343. https:\/\/doi.org\/10.1515\/intox-2017-0006","journal-title":"Interdiscip Toxicol"},{"issue":"5","key":"3639_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4062\/biomolther.2024.075","volume":"32","author":"JH Kim","year":"2024","unstructured":"Kim JH, Kim JS, Ju IG, Huh E, Choi Y, Lee S, Cho JY, Park BY, Oh MS (2024) Coadministration of 6-shogaol and levodopa alleviates parkinson\u2019s disease-related pathology in mice. Biomol Ther (Seoul) 32(5):523\u2013530. https:\/\/doi.org\/10.4062\/biomolther.2024.075","journal-title":"Biomol Ther (Seoul)"},{"key":"3639_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fpsyg.2011.00163","volume":"2","author":"E Aarts","year":"2011","unstructured":"Aarts E, van Holstein M, Cools R (2011) Striatal dopamine and the interface between motivation and cognition. Front Psychol 2:163. https:\/\/doi.org\/10.3389\/fpsyg.2011.00163","journal-title":"Front Psychol"},{"issue":"9","key":"3639_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.neurol.2018.07.002","volume":"174","author":"D Doummar","year":"2018","unstructured":"Doummar D, Moussa F, Nougues MC, Ravelli C, Louha M, Whalen S, Burglen L, Rodriguez D, Billette de Villemeur T (2018) Monoamine neurotransmitters and movement disorders in children and adults. Rev Neurol (Paris) 174(9):581\u2013588. https:\/\/doi.org\/10.1016\/j.neurol.2018.07.002","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"3639_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","volume":"4","author":"CJ Harmer","year":"2017","unstructured":"Harmer CJ, Duman RS, Cowen PJ (2017) How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry 4(5):409\u2013418. https:\/\/doi.org\/10.1016\/S2215-0366(17)30015-9","journal-title":"Lancet Psychiatry"},{"key":"3639_CR29","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.3389\/fpsyg.2018.02201","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu Y, Zhao J, Guo W (2018) Emotional roles of mono-aminergic neurotransmitters in major depressive disorder and anxiety disorders. Front Psychol 9:2201. https:\/\/doi.org\/10.3389\/fpsyg.2018.02201","journal-title":"Front Psychol"},{"issue":"Suppl 1","key":"3639_CR30","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.parkreldis.2020.09.024","volume":"80","author":"PA LeWitt","year":"2020","unstructured":"LeWitt PA, Chaudhuri KR (2020) Unmet needs in Parkinson disease: Motor and non-motor. Parkinsonism Relat Disord 80(Suppl 1):S7\u2013S12. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.09.024","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"3639_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.tins.2013.06.003","volume":"36","author":"L Brichta","year":"2013","unstructured":"Brichta L, Greengard P, Flajolet M (2013) Advances in the pharmacological treatment of Parkinson\u2019s disease: targeting neurotransmitter systems. Trends Neurosci 36(9):543\u2013554. https:\/\/doi.org\/10.1016\/j.tins.2013.06.003","journal-title":"Trends Neurosci"},{"issue":"Suppl 1","key":"3639_CR32","first-page":"4","volume":"69","author":"DJ Nutt","year":"2008","unstructured":"Nutt DJ (2008) Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 69(Suppl 1):4\u20137","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"3639_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41398-018-0183-x","volume":"8","author":"JX Pan","year":"2018","unstructured":"Pan JX, Xia JJ, Deng FL, Liang WW, Wu J, Yin BM, Dong MX, Chen JJ, Ye F, Wang HY, Zheng P, Xie P (2018) Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry 8(1):130. https:\/\/doi.org\/10.1038\/s41398-018-0183-x","journal-title":"Transl Psychiatry"},{"issue":"22","key":"3639_CR34","doi-asserted-by":"publisher","first-page":"e6698","DOI":"10.1097\/MD.0000000000006698","volume":"96","author":"C Zhuo","year":"2017","unstructured":"Zhuo C, Xue R, Luo L, Ji F, Tian H, Qu H, Lin X, Jiang R, Tao R (2017) Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis. Medicine (Baltimore) 96(22):e6698. https:\/\/doi.org\/10.1097\/MD.0000000000006698","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3639_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41398-022-02285-2","volume":"13","author":"L Boschloo","year":"2023","unstructured":"Boschloo L, Hieronymus F, Lisinski A, Cuijpers P, Eriksson E (2023) The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Transl Psychiatry 13(1):19. https:\/\/doi.org\/10.1038\/s41398-022-02285-2","journal-title":"Transl Psychiatry"},{"issue":"5","key":"3639_CR36","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41562-022-01502-8","volume":"7","author":"SE Qasim","year":"2023","unstructured":"Qasim SE, Mohan UR, Stein JM, Jacobs J (2023) Neuronal activity in the human amygdala and hippocampus enhances emotional memory encoding. Nat Hum Behav 7(5):754\u2013764. https:\/\/doi.org\/10.1038\/s41562-022-01502-8","journal-title":"Nat Hum Behav"},{"issue":"10","key":"3639_CR37","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s12272-018-1063-x","volume":"41","author":"J Lim","year":"2018","unstructured":"Lim J, Bang Y, Choi HJ (2018) Abnormal hippocampal neurogenesis in Parkinson\u2019s disease: relevance to a new therapeutic target for depression with Parkinson\u2019s disease. Arch Pharm Res 41(10):943\u2013954. https:\/\/doi.org\/10.1007\/s12272-018-1063-x","journal-title":"Arch Pharm Res"},{"issue":"2","key":"3639_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/mds.26112","volume":"30","author":"TJ van Mierlo","year":"2015","unstructured":"van Mierlo TJ, Chung C, Foncke EM, Berendse HW, van den Heuvel OA (2015) Depressive symptoms in Parkinson\u2019s disease are related to decreased hippocampus and amygdala volume. Mov Disord 30(2):245\u2013252. https:\/\/doi.org\/10.1002\/mds.26112","journal-title":"Mov Disord"},{"issue":"11","key":"3639_CR39","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/cns.12835","volume":"24","author":"FF Zhang","year":"2018","unstructured":"Zhang FF, Peng W, Sweeney JA, Jia ZY, Gong QY (2018) Brain structure alterations in depression: psychoradiological evidence. CNS Neurosci Ther 24(11):994\u20131003. https:\/\/doi.org\/10.1111\/cns.12835","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"3639_CR40","doi-asserted-by":"publisher","first-page":"E311","DOI":"10.1503\/jpn.220083","volume":"47","author":"TJ McDermott","year":"2022","unstructured":"McDermott TJ, Berg H, Touthang J, Akeman E, Cannon MJ, Santiago J, Cosgrove KT, Clausen AN, Kirlic N, Smith R, Craske MG, Abelson JL, Paulus MP, Aupperle RL (2022) Striatal reactivity during emotion and reward relates to approach-avoidance conflict behaviour and is altered in adults with anxiety or depression. J Psychiatry Neurosci 47(5):E311\u2013E322. https:\/\/doi.org\/10.1503\/jpn.220083","journal-title":"J Psychiatry Neurosci"},{"issue":"12","key":"3639_CR41","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","volume":"20","author":"P Belujon","year":"2017","unstructured":"Belujon P, Grace AA (2017) Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol 20(12):1036\u20131046. https:\/\/doi.org\/10.1093\/ijnp\/pyx056","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"3639_CR42","first-page":"227","volume":"46","author":"D Weintraub","year":"2005","unstructured":"Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB, Mozley D, Katz IR (2005) Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson\u2019s disease. J Nucl Med 46(2):227\u2013232","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-025-03639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00394-025-03639-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-025-03639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:05:24Z","timestamp":1744805124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00394-025-03639-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3639"],"URL":"https:\/\/doi.org\/10.1007\/s00394-025-03639-4","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"116"}}